Short answer · Medically reviewed summary · Last updated: 2026-04-07
Schnitzler syndrome is a rare acquired autoinflammatory disorder characterized by chronic urticarial rash and recurrent fever, though its exact cause remains unknown. While it is classified as an autoinflammatory condition, current research indicates it is likely driven by the overproduction of the inflammatory protein interleukin-1 (IL-1), rather than being a strictly inherited genetic disease. What is the underlying cause of Schnitzler syndrome? The exact cause of Schnitzler syndrome is still under investigation, but it is categorized as an acquired autoinflammatory disease.
Schnitzler syndrome is a rare acquired autoinflammatory disorder characterized by chronic urticarial rash and recurrent fever, though its exact cause remains unknown. While it is classified as an autoinflammatory condition, current research indicates it is likely driven by the overproduction of the inflammatory protein interleukin-1 (IL-1), rather than being a strictly inherited genetic disease.
The exact cause of Schnitzler syndrome is still under investigation, but it is categorized as an acquired autoinflammatory disease. Unlike autoimmune diseases where the body attacks its own tissues, autoinflammatory conditions like Schnitzler syndrome involve a "misfiring" of the innate immune system. In patients with this condition, the immune system remains in a state of constant activation, leading to the systemic inflammation that characterizes the disease. Researchers believe that the dysregulated production of interleukin-1 (IL-1), a powerful inflammatory messenger, is the primary driver of symptoms.
Current clinical evidence suggests that Schnitzler syndrome is not an inherited or genetic disease. Unlike many other autoinflammatory syndromes that are caused by specific gene mutations (such as those in the NLRP3 gene), no single gene mutation has been identified as the cause of Schnitzler syndrome. Because it is an acquired condition, it typically develops in adulthood, with most patients receiving a diagnosis between the ages of 50 and 70. There is no evidence to suggest that parents can pass this condition to their children.
While the triggers for Schnitzler syndrome are not well-defined, the condition is consistently associated with the presence of a monoclonal gammopathy—an abnormal protein (usually IgM or IgG) found in the blood. However, it is important to distinguish between a cause and a risk factor:
Medical researchers are actively working to bridge the gap between the monoclonal protein and the clinical inflammation seen in Schnitzler syndrome. Because patients often respond dramatically to IL-1 blockade therapy (such as anakinra), the central role of the IL-1 pathway is now well-established. Future research is focused on understanding why certain individuals with monoclonal gammopathy go on to develop the full systemic inflammatory response of Schnitzler syndrome while others do not. At DiseaseMaps.org, our community of 54 members continues to provide valuable longitudinal data that helps researchers understand the real-world progression of this rare, complex condition.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.